The trademark application IMFECTIMUNE was filed by PDS Biotechnology Corporation, a U.S. corporation (the "Applicant"). Application withdrawn.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with Pharmaceutical research services, namely, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates.